Charité Ricker

2.0k total citations
60 papers, 1.1k citations indexed

About

Charité Ricker is a scholar working on Genetics, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Charité Ricker has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 22 papers in Pathology and Forensic Medicine and 18 papers in Cancer Research. Recurrent topics in Charité Ricker's work include BRCA gene mutations in cancer (43 papers), Genetic factors in colorectal cancer (21 papers) and Cancer Genomics and Diagnostics (17 papers). Charité Ricker is often cited by papers focused on BRCA gene mutations in cancer (43 papers), Genetic factors in colorectal cancer (21 papers) and Cancer Genomics and Diagnostics (17 papers). Charité Ricker collaborates with scholars based in United States, Puerto Rico and Spain. Charité Ricker's co-authors include Jeffrey N. Weitzel, Kathleen R. Blazer, Veronica I. Lagos, Josef Herzog, Susan L. Neuhausen, Nancy Feldman, Katrina Lowstuter, Rebecca A. Nelson, Colleen McGuire and Deborah J. MacDonald and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Charité Ricker

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charité Ricker United States 17 871 297 262 258 213 60 1.1k
Daniela Turchetti Italy 21 589 0.7× 397 1.3× 293 1.1× 250 1.0× 219 1.0× 94 1.2k
Lisa R. Susswein United States 15 575 0.7× 236 0.8× 249 1.0× 192 0.7× 331 1.6× 25 913
Amy Finch Canada 18 1.1k 1.3× 198 0.7× 205 0.8× 333 1.3× 256 1.2× 29 1.6k
Amanda Gammon United States 18 678 0.8× 261 0.9× 251 1.0× 317 1.2× 282 1.3× 34 1.1k
Kathleen R. Blazer United States 21 1.1k 1.2× 376 1.3× 388 1.5× 359 1.4× 378 1.8× 49 1.4k
Mercedes Castiel United States 12 825 0.9× 194 0.7× 220 0.8× 311 1.2× 249 1.2× 16 1.4k
Susan Randall Armel Canada 21 963 1.1× 331 1.1× 352 1.3× 536 2.1× 251 1.2× 51 1.5k
Kristen M. Shannon United States 19 771 0.9× 342 1.2× 312 1.2× 419 1.6× 570 2.7× 43 1.5k
Leon C. Verhoog Netherlands 8 860 1.0× 209 0.7× 411 1.6× 337 1.3× 251 1.2× 9 1.1k
Rachel Nusbaum United States 17 785 0.9× 155 0.5× 175 0.7× 176 0.7× 142 0.7× 28 1.0k

Countries citing papers authored by Charité Ricker

Since Specialization
Citations

This map shows the geographic impact of Charité Ricker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charité Ricker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charité Ricker more than expected).

Fields of papers citing papers by Charité Ricker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charité Ricker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charité Ricker. The network helps show where Charité Ricker may publish in the future.

Co-authorship network of co-authors of Charité Ricker

This figure shows the co-authorship network connecting the top 25 collaborators of Charité Ricker. A scholar is included among the top collaborators of Charité Ricker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charité Ricker. Charité Ricker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Culver, Julie O., Charité Ricker, Kerry Kingham, et al.. (2025). Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing. JAMA Network Open. 8(1). e2454447–e2454447. 1 indexed citations
2.
Ricker, Charité, Banu Arun, Sara Pirzadeh‐Miller, et al.. (2024). Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights. JCO Oncology Practice. 20(10). 1308–1313. 3 indexed citations
3.
Hodan, Rachel, et al.. (2024). Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients. Journal of Community Genetics. 15(4). 363–374. 1 indexed citations
4.
Culver, Julie O., Yuxi Liu, Charité Ricker, et al.. (2023). Clinical implications of conflicting variant interpretations in the cancer genetics clinic. Genetics in Medicine. 25(7). 100837–100837. 3 indexed citations
5.
Hodan, Rachel, Linda Rodgers, Sanjeevani Arora, et al.. (2023). Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey. Frontiers in Oncology. 13. 1141810–1141810. 6 indexed citations
6.
Ricker, Charité, et al.. (2022). Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care. Gastroenterology. 164(1). 5–8. 3 indexed citations
7.
Vadaparampil, Susan T., Lindsay Fuzzell, Jennifer García, et al.. (2021). Development and pilot testing of a training for bilingual community education professionals about hereditary breast and ovarian cancer among Latinas: ÁRBOLES Familiares. Translational Behavioral Medicine. 12(1). 12 indexed citations
8.
In, Gino K., Kevin G. King, Omar Ragab, et al.. (2020). PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California. Journal of Cancer Research and Clinical Oncology. 147(6). 1803–1811. 23 indexed citations
9.
Ciccone, Marcia A., Teena Thakur, Charité Ricker, et al.. (2020). Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells. Gynecologic Oncology. 159(3). 869–876. 6 indexed citations
10.
Weitzel, Jeffrey N., Susan L. Neuhausen, Aaron W. Adamson, et al.. (2019). Pathogenic and likely pathogenic variants in PALB2 , CHEK2 , and other known breast cancer susceptibility genes among 1054 BRCA ‐negative Hispanics with breast cancer. Cancer. 125(16). 2829–2836. 36 indexed citations
11.
Raghavendra, Akshara Singareeka, Julie S. Wecsler, Lingyun Ji, et al.. (2018). Clinical findings and outcomes of MRI staging of breast cancer in a diverse population. Breast Cancer Research and Treatment. 174(2). 315–324. 3 indexed citations
12.
Matsuo, Koji, Marcia A. Ciccone, Erin A. Blake, et al.. (2018). Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series. Gynecologic Oncology Reports. 25. 98–101. 20 indexed citations
13.
14.
Sunga, Annette Y., Charité Ricker, Carin R. Espenschied, et al.. (2017). Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome. Cancer Genetics. 212-213. 1–7. 8 indexed citations
15.
Ricker, Charité, Julie O. Culver, Katrina Lowstuter, et al.. (2016). Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort. Cancer Genetics. 209(4). 130–137. 60 indexed citations
16.
Press, Michael F., et al.. (2011). Pathological characteristics of BRCA-associated breast cancers in Hispanics. Breast Cancer Research and Treatment. 130(1). 281–289. 16 indexed citations
17.
Weitzel, Jeffrey N., Arelis Martir-Negron, Josef Herzog, et al.. (2011). Prevalence and ancestral origin of BRCA mutations in the Hispanic population: Insights for ancestry-informed genetic cancer risk assessment.. Journal of Clinical Oncology. 29(15_suppl). 1514–1514. 1 indexed citations
18.
Lagos, Veronica I., Martin A. Perez, Charité Ricker, et al.. (2008). Social‐cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer. Psycho-Oncology. 17(8). 774–782. 41 indexed citations
19.
Weitzel, Jeffrey N., et al.. (2006). Impact of genetic cancer risk assessment on cancer screening and prevention behaviors in an underserved predominantly Latina population.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations
20.
Blazer, Kathleen R., Deborah J. MacDonald, Charité Ricker, et al.. (2005). Outcomes from intensive training in genetic cancer risk counseling for clinicians. Genetics in Medicine. 7(1). 40–47. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Turchetti Breakdown of academic impact, for papers by Lisa R. Susswein Breakdown of academic impact, for papers by Amy Finch Breakdown of academic impact, for papers by Amanda Gammon Breakdown of academic impact, for papers by Kathleen R. Blazer Breakdown of academic impact, for papers by Mercedes Castiel Breakdown of academic impact, for papers by Susan Randall Armel Breakdown of academic impact, for papers by Kristen M. Shannon Breakdown of academic impact, for papers by Leon C. Verhoog Breakdown of academic impact, for papers by Rachel Nusbaum
Rankless by CCL
2026